# inHEART

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inheart

- Industry: Healthcare IT
- Headquarters: Pessac, France
- Website: www.inheartmedical.com
- Total disclosed funding: $3.6M
- Latest round: Seed (Jul 1, 2020)
- Investors on record: 1

## About

Established in 2017 and based in Pessac, France, inHEART operates as a developer of a cloud-based 3D  medical image and cardiac analysis solution that enables to capture and visualize patients with heart rhythm disorders to reduce failure and time of treatment procedures. In May 2024, inHEART raised USD 11 million in venture funding co-led by investors Vesalius Biocapital and Elaia Partners. The firm, as of July 2024, has offices in Pessac France, and Massachusetts, US, and is led by its President, CEO, and Chairman, Todar Jeliaskov, and founder and CIO, Jean Marc Petrat.

inHEART specializes in creating AI-enabled digital twins of the heart, supporting image-guided therapies for cardiac ablations. The company leverages its proprietary segmentation algorithm to transform CT and MRI scans into detailed 3D models. These models offer insights into cardiac anatomy, aiding physicians in precise treatment planning and enhancing procedural efficiency. Additionally, inHEART’s solutions integrate with major electroanatomic mapping systems, supporting real-time navigation during procedures and reducing both procedure times and recurrence rates significantly.

The company plans to utilize May 2024 funding to enhance the diagnosis of sickness by offering cardiac patients improved therapeutic support.

## Funding rounds

- Seed, Jul 1, 2020, $3.6M — Elaia Partners

## Investors

- Elaia Partners (https://capitalatlas.ai/funds/elaia-partners) — Seed